Cellular and Molecular Medicine Seminar: ‘KRAS-and RIT1-mutant Lung Cancer’

The University of Arizona Department of Cellular and Molecular Medicine presents:

“Integrative Functional Genomics of KRAS-and RIT1-mutant Lung Cancer”

Alice Berger, PhD | Assistant Member, Fred Hutchinson Cancer Research Center, and Affiliate Assistant Professor, Genome Sciences, University of Washington, Seattle

Thursday, Nov. 14, 2019
Noon-1:00 p.m.
Health Sciences Innovation Building, Room 880

About the Speaker:
Dr. Alice Berger is an Assistant Member in Human Biology and Public Health Sciences, and the Innovators Network Endowed Chair at Fred Hutch. Dr. Berger is an expert in discovering how changes to our genetic code lead to cancer. She works to translate these insights into new drug targets and biomarkers to benefit patients. Deep examinations of the genetic code in tumors highlight many mutations, or alterations in DNA sequence — but it’s not always clear which mutations are important or how they will affect the function of the protein encoded by the altered gene. Dr. Berger has developed methods that help assess both the functional consequences of gene alterations and how these changes lead to cancer. In particular, she focuses on lung adenocarcinoma and the role that changes to a gene called RIT1 play in tumor formation. By better understanding the function of RIT1 and the molecular pathways it regulates, Dr. Berger hopes to discover possible targets for new therapies.

CMM Seminar Announcement (please post and share with colleagues):
Seminar Announcement - Berger.pdf   

To request any disability-related accommodations for this event please contact the event coordinator at least three business days prior to the event.